市場調査レポート

商品コード

1498612

バイオテクノロジーの市場規模、シェア、成長分析、タイプ別、製品別、技術別、用途別、地域別 - 産業予測、2024～2031年

Biotechnology Market Size, Share, Growth Analysis, By Type, By Product(Instrument & Reagent ), By Technology, By Application, By Region - Industry Forecast 2024-2031

出版日: 2024年06月09日
発行: SkyQuest
ページ情報: 英文 260 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 760,921円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 890,134円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,019,347円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
目次

概要

サンプル依頼リストに入れる

バイオテクノロジーの市場規模は、2022年に1兆2,100億米ドルとなり、2023年の1兆3,800億米ドルから、2031年までには3兆9,000億米ドルに成長し、予測期間中（2024～2031年）のCAGRは13.9%で成長する見通しです。

米国、中国、インドでは人口が増加しており、小麦、米、サトウキビなどの主食に対する需要が増加し、その経済的重要性が高まっています。同時に科学者たちは、水不足、農業生産性、害虫駆除などの問題に対する解決策を、革新的な技術や共同研究に焦点を当てて集中的に研究しています。政府と民間セクターのイニシアティブにより、バイオテクノロジーへの資金援助が強化され、研究開発と製品開発が支援されています。糖尿病やがんなどの慢性疾患が世界的に流行するにつれ、バイオテクノロジー分野では先進的な治療法に対する需要の高まりが予想され、バイオテクノロジーイノベーションを専門とする企業に有望な展望を提供しています。

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他欧州地域
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主要な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

AstraZeneca（UK）
Gilead Sciences, Inc.（US）
Biogen Inc.（US）
Merck（Germany）
Illumina, Inc.（US）
Novo Nordisk A/S（Denmark）
Thermo Fisher Scientific Inc.（US）
Agilent Technologies, Inc.（US）
Lonza Group AG（Switzerland）
Pfizer Inc.（US）
Bristol-Myers Squibb（US）
Amgen Inc.（US）
AbbVie Inc.（US）
Regeneron Pharmaceuticals, Inc.（US）
Vertex Pharmaceuticals Incorporated（US）
Roche Holding AG（Switzerland）
Bio-Rad Laboratories, Inc.（US）
Moderna, Inc.（US）
Qiagen N.V.（Netherlands）
Johnson & Johnson Services, Inc.（US）

Product Code: SQMIG35H2249

Biotechnology Market size was valued at USD 1.21 Trillion in 2022 and is poised to grow from USD 1.38 Trillion in 2023 to USD 3.90 Trillion by 2031, growing at a CAGR of 13.9% during the forecast period (2024-2031).

The biotech industry is globally interconnected and driven by diverse economic growth across nations, with investments expected to rise due to pressing health challenges like hepatitis B. Population growth in the US, China, and India is increasing demand for staple foods such as wheat, rice, and sugarcane, heightening their economic importance. Concurrently, scientists are intensively researching solutions to issues like water scarcity, agricultural productivity, and pest control, focusing on innovative technologies and collaborations. Government and private sector initiatives bolster biotech funding, supporting R&D and product development. As chronic diseases like diabetes and cancer become more prevalent worldwide, the biotech sector anticipates heightened demand for advanced treatments, offering promising prospects for companies specializing in biotech innovation.

Top-down and bottom-up approaches were used to estimate and validate the size of the Biotechnology Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Biotechnology Market Segmental Analysis

The biotechnology market is segmented by type, product, technology, application, and region. Based on type the market is segmented into Blue Biotechnology, Green Biotechnology, Red Biotechnology, White Biotechnology, and Others. Based on product the market is segmented into Instrument & Reagent (Clinical Diagnostics, Proteomics and genomics, Drug Discovery & Development, Cell Analysis, Others), Software & Service. Based on technology, the market can be segmented into Nanobiotechnology, PCR Technology, Bioinformatics, Tissue Engineering, DNA sequencing, Fermentation Technology, and others. Based on application, the market is segmented into Health, Agriculture, Food and Beverages, Industrial Processing, and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Biotechnology Market

The biotechnology market is currently driven by advancements in cell and tissue development research, expected to fuel its growth in the coming years. A notable example is Bharat Biotech, an Indian pharmaceutical company, which in August 2022 released phase III clinical trial data for their nasal spray COVID-19 vaccine variant, BBV-154. These trials demonstrated the vaccine's safety and tolerability, receiving approval from the Drug Controller General of India (DCGI) for further comparative studies against Covaxin. This development underscores the market's trajectory towards innovative biotechnological solutions, particularly in vaccine development, influencing the industry's expansion and future prospects significantly.

Restraints in the Biotechnology Market

Legend Biotech Corporation, a U.S.-based biotechnology company specializing in innovative therapies, halted a Phase 1 clinical trial for their CAR-T product after determining it did not meet anticipated outcomes, affecting the biotechnology market's momentum. This decision, communicated to the U.S. FDA, underscores challenges in biotech research where trials may not yield expected clinical benefits. Specifically, in July 2022, Legend Biotech terminated its Investigational New Drug (IND) application for L, a CAR-T therapy, due to findings suggesting no significant therapeutic efficacy akin to their CAR-T product LB1901 under trial in China. Such setbacks can impede growth in the biotechnology sector, influencing investor confidence and research strategies moving forward.

Market Trends of the Biotechnology Market

DNA sequencing has become a pivotal force in the market, driven significantly by cost reductions and the incorporation of advanced techniques. The decreasing expenses and the application of sophisticated methodologies have cemented its critical role in both research and diagnostics, contributing to its widespread acceptance and substantial influence on the market landscape. The increasing accessibility of DNA sequencing not only fosters innovation in genetic research but also enhances its utility in clinical settings, thereby fueling its expansion and market prominence.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Value Chain Analysis
Ecosystem of the Market
Case Study Analysis
Pipeline Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Biotechnology Market by Type

Market Overview
Blue Biotechnology
Green Biotechnology
Red Biotechnology
White Biotechnology
Others

Biotechnology Market by Product

Market Overview
Instrument & Reagent
- Clinical Diagnostics
- Proteomics and genomics
- Drug Discovery & Development
- Cell Analysis
- Others
Software & Service

Biotechnology Market by Technology

Market Overview
Nanobiotechnology
PCR Technology
Bioinformatics
Tissue Engineering and Regeneration
Cell-based Assays
DNA sequencing
Fermentation Technology
Chromatography
Others

Biotechnology Market by Application

Market Overview
Health
Agriculture
Food and Beverages
Natural Resources & Environment
Industrial Processing
Others

Biotechnology Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

AstraZeneca (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gilead Sciences, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biogen Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novo Nordisk A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza Group AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bristol-Myers Squibb (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amgen Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AbbVie Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Regeneron Pharmaceuticals, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vertex Pharmaceuticals Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Holding AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (US
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Moderna, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qiagen N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson Services, Inc.(US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

バイオテクノロジーの市場規模、シェア、成長分析、タイプ別、製品別、技術別、用途別、地域別 - 産業予測、2024～2031年

Biotechnology Market Size, Share, Growth Analysis, By Type, By Product(Instrument & Reagent ), By Technology, By Application, By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主要な市場の考察

バイオテクノロジー市場：タイプ別

バイオテクノロジー市場：製品別

バイオテクノロジー市場：技術別

バイオテクノロジー市場：用途別

バイオテクノロジー市場規模：地域別